You are here

Article Text

Article menu
Download PDFPDF
Commentary
Use of a preclinical model of pancreas cancer to identify potential candidates for rapalogue therapy

https://doi.org/10.1136/gutjnl-2014-307317

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors Both authors contributed equally to the preparation of this commentary.

    • Competing interests None.

    • Patient consent Obtained.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles

    • Pancreas
      Targeting mTOR dependency in pancreatic cancer
      Douglas C Morran Jianmin Wu Nigel B Jamieson Agata Mrowinska Gabriela Kalna Saadia A Karim Amy Y M Au Christopher J Scarlett David K Chang Malgorzata Z Pajak Australian Pancreatic Cancer Genome Initiative (APGI) Karin A Oien Colin J McKay C Ross Carter Gerry Gillen Sue Champion Sally L Pimlott Kurt I Anderson T R Jeffry Evans Sean M Grimmond Andrew V Biankin Owen J Sansom Jennifer P Morton
      Gut 2014; 63 1481-1489 Published Online First: 09 Apr 2014. doi: 10.1136/gutjnl-2013-306202